- Home
- / Sana Biotechnology
Sana Biotechnology
Stock Price
$4
2023-12-05
Market Capitalization
$806.3 M
2023-12-05
Sana Biotechnology Summary
Company Summary
- Overview
- Sana Biotechnology is a company specializing in cell and gene therapy. It focuses on creating and delivering engineered cells as medicines for patients. The company deploys a platform that can repair and control genes in cells or replace any cell in the body.
- Type
- Public
- Status
- Active
- Founded
- 2018
- HQ
- Seattle, WA, US | view all locations
- Website
- https://sana.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Robin Andrulevich, Chief People Officer
Nate Hardy, Chief Financial Officer
Christian Hordo, Chief Business Officer
Operating MetricsView all
Pre-Clinical Phase Products
14
Q3, 2020
LocationsView all
3 locations detected
Seattle, WA HQ
United States
188 E Blaine St #400
Cambridge, MA
United States
300 Tech Square, 300 Technology Square #700
South San Francisco, CA
United States
1 Tower Pl #500
Sana Biotechnology Financials
Summary Financials
- Net income (Q3, 2023)
- $984.0K
- Cash (Q3, 2023)
- $168.4M
- EBIT (Q3, 2023)
- ($2.2M)
- Enterprise value
- $747.1M